Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Prophylaxis for Ureteral Stent Removal
NCT02944825Completed
- Sponsor
- University of California, San Diego
- Start
- Jan 2016
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of ciprofloxacin in urinary tract infection (UTI) (2 arms), sponsored by University of California, San Diego. Primary endpoint: Post-procedure Infectious Complication at 30 days. Started Jan 2016; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT02944825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02944825.